Last Price: 1.15

TTM Dividend Yield : 0%

Coming Quarter Report: ~ 2021-05-22

Yahoo Google Bursa Web TradingView

Sector: Biotechnology & Medical Research

Malaysian Genomics Resource Centre Berhad is a Malaysia-based investment holding company. The Company is engaged in providing genome sequencing, bioinformatics analysis services and genetic screening services, and providing online access to genomic data and bioinformatics applications. The Company offers sequencing services for genomes, transcriptomes and metagenomes. Its Genome Sequencing Services include Whole Genome Sequencing, Transcriptome Sequencing, and Metagenomics and Metatranscriptomics. Its Genome Analysis Services include Bioinformatics, Trait Analysis and Trio Sequencing. Its Genetic Screening Services (GSS) are designed to provide information about deoxyribonucleic acid (DNA). It offers both de novo sequencing and resequencing as part of its Whole Genome Sequencing service. Its GSS offers Dtect, which is a range of test panels designed to screen for genetic markers in an individual’s DNA. It offers its services in healthcare, agriculture and aquaculture industries.

**Do feedback to us if you see any error on the data


MGRC Dividend Yield Trend

MGRC Quarter DY Yield

MGRC Annual DY Yield


MGRC Quarter Report History

MGRC Quarter Profit Trend

MGRC Annual Profit Trend

Cash Flow

Cash Flow

In financial accounting, operating cash flow (OCF), cash flow provided by operations, cash flow from operating activities (CFO) or free cash flow from operations (FCFO), refers to the amount of cash a company generates from the  revenues it brings in, excluding  costs associated with long – term  investment  on capital items or investment in securities.(From Wiki)

MGRC Annual Cash Flow



  1. Malaysian Genomics Resource Centre Bhd is a Malaysia based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) service, genetic screening services (GSS) and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtec which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of the revenue from the Pathology services.


Leave a Reply

Your email address will not be published. Required fields are marked *